Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Quote:
"Oh Yes of course! It's all on the internet you can look it up very easy to find."
What grants have they received ? Other than DOE. Have they collected any funds from these grants
There are no federal grants anymore. Federal agencies can't fund a company in chapter 11 so that avenue is gone.
In bankruptcy filings yes all the financials are on the table. But why havent they filed with SEC ??
The issue is not filing. The issue is VIICQ not filing. They were current until they filed for bankruptcy. Now they don't care? Not a move towards reassurance to common stockholders.
Common knowledge a company has to keep up with filings.
What does that have to do with anything. The SEC will not be involved in the bankruptcy... okay. They still have to be current in filings as a publicly traded company.
NO SEC Filings. Shares will be wiped out.
Website is back up. Redesigned. Still adding and updating
That was my thought originally but 84% of all shares are pretty much locked up and that 84% stays the same even with the increase so hypothetically increase to 10 billion happens that leaves a 1.2 billion that they could dilute in the next 4 months but they don't want to do that does it only hurt themselves financing is pretty much in place for the next 12 to 18 months and don't forget to also want to implement a reverse split also the news of 10 billion has been out for a couple weeks if it was going to crash big time it already would have
Allergan and Mentor are the two largest companies one of those two companies had VeriTeQ design a prototype it is in the annual report and both are huge who was it
That is my focus going forward with all the FDA regulations have just gone into effect we're going to see some major movements the recent order of a hundred Q inside readers I'm curious who bought those we know its not motiva we already know about them in the annual report it said they were doing a prototype for the number one or number 2 largest breast implant manufacturer in the world so who was it that bought those hundred about a month ago
Certainly nothing new. 3Q Sales better than 2Q
NEWS OUT
It's Brewing. Any pressure and its off to the races.
Yes they have an ongoing funding relationship with several lenders. They have funding being sewn up. With the financing out of the way the announcements to come of major contracts will send us moving.
We get any ask slapping. Its clear sailing
Website is still down. Looking to see major updates this week on contracts.
Q Inside SmartMarker is an implantable radiation sensor for use in breast and prostate cancer patients undergoing photon external beam treatments. It is implanted in, or adjacent to, solid-mass tumors and gathers data on the actual dose of radiation being delivered to the tumor and surrounding normal tissue. Q Inside SmartMarker is intended to be used in the balancing between delivering maximum dose to the tumor while minimizing the impact to healthy tissue. The sensor can confirm the treatment is conforming to the physician's plan, as even a small deviation from the planned dose can have a significant impact on patient survival rates.
VeriTeQ's OneDose external radiation sensing system is FDA cleared for use in patients being treated with external beam radiation. OneDose is a proprietary, wearable, single-use system that is used to verify radiation oncology doses quickly and conveniently. The OneDose system is comprised of disposable sensors that attach to the patient's skin using a basic adhesive and a scanner that reads the sensor. VeriTeQ believes OneDose is the only wireless, pre-calibrated, disposable, skin surface sensor that provides instant dose delivery data, which could be fed into patient radiology reports and health records.
DELRAY BEACH, Fla., Nov. 5, 2014 (GLOBE NEWSWIRE) -- VeriTeQ Corporation (OTC Markets:VTEQ) ("VeriTeQ" or the "Company"), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that it has entered into a securities purchase agreement (the "SPA") and convertible note with Magna Equities II, LLC ("Magna"). Under the SPA, the Company expects to issue additional promissory notes on substantially identical terms throughout November and December for total net proceeds of up to $450,000.
In conjunction with the financing, Magna has purchased from Hudson Bay Master Fund Ltd. two promissory notes issued by the Company in November 2013 and May 2014, with a current principal amount totaling approximately $352,000. Under the terms of the financing, the maturity date of the notes due November 13, 2014, has been extended to July 13, 2015. Also in connection with entering into the SPA with Magna, the Company entered into agreements with its Chief Executive Officer, Scott R. Silverman, to convert $1.4 million owed to him, and with its President, Randolph Geissler, to convert $441,000 owed to him, into a total of 1,841 shares of the Company's newly designated Series D Convertible Preferred Stock, which will vest/convert on January 1, 2017, or upon a change of control.
"We believe this new financing agreement with Magna, with whom we have worked for several months, will result in a positive outcome for the Company and our stockholders," said Silverman. "We continue to have confidence in in the opportunities for our business, and look forward to cementing relationships with strong partners for the continued expansion of our technology around the world."
Additional terms of the financing and the conversion of liabilities owed to Messrs. Silverman and Geissler are discussed in the Company's Form 8-K filed with the SEC on November 5, 2014.
The large number of authorized shares is desirable for two reasons: (1) It is common in financing transactions for investors to insist on a share reserve, which are shares set aside that will not be issued to others and may be issued, but not necessarily will be issued, pursuant to the terms of the convertible instrument and warrants. Such reserves are often far in excess of the number of shares that could be converted/exercised at current stock prices. The Company has been requested for excess share reserves ranging from 25% to 400% of the hypothetical issuance as an additional share reserve. Such excess reserved shares are not necessarily to be issued; they are a cushion in case the stock price falls. As such, the Company needs far more shares authorized than it expects to actually issue.
The stock price, which as of October 31, 2014 closed at a price per share of $0.0031, is extremely low, and has fallen considerably. We have no assurance that our stock price will improve and it may fall further. Consequently, the lower stock price has resulted in a considerably higher number of issuable shares for existing convertible debt and any similar financing that we expect to require in the future and while the Company is hopeful that the price improves, it recognizes that to execute on its plan it will need to engage in equity based or convertible financing transactions. At the current market price, the company would require the large number of authorized shares to be available for potential financing transactions. The terms of its recent financings have been consistent in that they have all been convertible debt, therefore requiring shares, and moreover requiring the enhanced reserve described above.
Float 22.5 Million. We go Boooooooooom
EZirish Close to being a Beneficial Owner With 4% Very Nice.
EZirish Quote : Between my TD and Scottrade accounts I own just shy of 8 million shares.
Corbin Properties LLC Owns 8.7 %
11/13/14 75.9 % Locked Up 8 Directors & Executives.
11/13/2014 198,986,840 shares of our common stock currently issued and outstanding.
It seems to me doing my due dils that they have locked up funding through 2015. Earliest point of any dilution would be july of 2015. It looks to me like they believe they will have enough money coming in by then that they never have to issue any of the 10 billion it looks like a safety net.
VTEQ is a ticking time BOOOOOOM. Smelling Big Contracts Looming
Looking for strong volume ahead of Q3 today.
Q3 Report Due Out Today or Tomorrow
Given the breakdown in communication and existing relationship between the attorney (Marshack) and client (Vision), good cause exists for the Court to enter an Order relieving the Firm as Debtor's counsel of record.
Quote "VIIC has a very profitable line of technology" . Not profitable at all. Forget about profits, they dont even have revenue.
You could hear a pin drop
Commercialization will never start. Liquidation however rapidly approaches.
Maybe we see .0008 quicker than anyone thought
The reason they are "interested party' is because Vision put the truck up for collateral and TTSI holds the note.
A little shake rattle and roll.
The bottom will fall out. There is no need to keep the company intact it makes no sense to try. If they present evidence to the judge that they have no way of continuing as a viable effort because they have no foreseeable revenue then the judge can accept their request and immediately move to chapter 7. End Of Chapter. In a year or so once the infrastructure is in place they begin a new startup.